Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

Aggressive adult T-cell leukemia/lymphoma (ATL) is a hematological malignancy that is difficult to treat with chemotherapy alone, and allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy. We conducted a multicenter, prospective, observational study to clarify th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Ayumu, Nakano, Nobuaki, Tanaka, Takashi, Fuji, Shigeo, Makiyama, Junya, Inoue, Yoshitaka, Choi, Ilseung, Nakamae, Hirohisa, Nagafuji, Koji, Takase, Ken, Machida, Shinichiro, Takahashi, Tsutomu, Sawayama, Yasushi, Kamimura, Tomohiko, Kato, Koji, Kawakita, Toshiro, Ogata, Masao, Sakai, Rika, Shiratori, Souichi, Uchimaru, Kaoru, Inamoto, Yoshihiro, Utsunomiya, Atae, Fukuda, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945611/
https://www.ncbi.nlm.nih.gov/pubmed/34500464
http://dx.doi.org/10.1182/bloodadvances.2021004932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945611/
https://www.ncbi.nlm.nih.gov/pubmed/34500464
http://dx.doi.org/10.1182/bloodadvances.2021004932

Ejemplares similares